Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 21, 2004
Consecutive-dose pharmacokinetics of rifapentine in patients diagnosed with pulmonary tuberculosisG Langdon, J J Wilkins, P J Smith, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 9, 2002
Widespread distribution of a single drug rifampicin formulation of inferior bioavailability in South AfricaH McIlleron, P Wash, A Burger, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 11, 1999
The development of a standardised screening protocol for the in vivo assessment of rifampicin bioavailabilityH McIlleron, G Gabriels, P J Smith, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 1, 2007
Modification to improve efficiency of sampling schedules for BA/BE testing of FDC anti-tuberculosis drugsG A Gabriels, H McIlleron, P J Smith, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 14, 2015
The pharmacokinetics of lopinavir/ritonavir when given with isoniazid in South African HIV-infected individualsE H Decloedt, J S van der Walt, H McIlleron, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 18, 2018
Quality assurance of rifampicin-containing fixed-drug combinations in South Africa: dosing implicationsR Court, M T Chirehwa, L Wiesner, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 7, 2014
Isoniazid/acetylisoniazid urine concentrations: markers of adherence to isoniazid preventive therapy in childrenV Amlabu, C Mulligan, N Jele, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 4, 2018
Steady state pharmacokinetics of cycloserine in patients on terizidone for multidrug-resistant tuberculosisR Court, L Wiesner, A Stewart, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 11, 1999
Recent bioequivalence studies on fixed-dose combination anti-tuberculosis drug formulations available on the global marketG Pillai, P B Fourie, N Padayatchi, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 20, 2019
Effect of tablet crushing on drug exposure in the treatment of multidrug-resistant tuberculosisR Court, M T Chirehwa, L Wiesner, et al.
Pageof 3